Recall two batches of Trepadio 50 mg and 100 mg FCT

Recall two batches of Trepadio 50 mg and 100 mg FCT

2025-01-05

Product Description :

 

الاسم التجاري

الاسم العلمي

رقم التسجيل

رقم التشغيلة المتأثرة

الشركة الصانعة

Trade Name

Scientific Name

Register Number

Affected batch number

Manufacturer

Trepadio 50 mg FCT

LACOSAMIDE

2103221859

6480

Jazeera Pharmaceutical Industries (JPI)

Trepadio 100 mg FCT

2102221756

6477

Issue :

Saudi FDA issued Recall two batches of Trepadio 50 mg and 100 mg FCT due to not comply with the approved specifications. Jazeera Pharmaceutical Industries (JPI) is voluntarily recalling batches.

Recommendations :

For healthcare professionals, Stop dispensing the above batches immediately. Embargo/Quarantine all remaining stock. Affected batches should be returned to the supplier.

for patients

  • Consult your healthcare provider prior to discontinuing use of the affected batches, or for any health concerns.
  • Contact the recalling firm or Saudi FDA if you have any questions about the recall.
  • Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).


Recall two batches of Trepadio 50 mg and 100 mg FCT